本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

TELA Bio, Inc.

1.14
+0.140714.08%
盘后1.290.1500+13.16%17:17 EST
成交量:121.83万
成交额:148.08万
市值:4,598.93万
市盈率:-1.09
高:1.25
开:1.00
低:1.00
收:0.9993
52周最高:3.20
52周最低:0.8645
股本:4,034.15万
流通股本:1,841.61万
量比:2.96
换手率:6.62%
股息:- -
股息率:- -
每股收益(TTM):-1.0487
每股收益(LYR):-1.3265
净资产收益率:-676.41%
总资产收益率:-36.47%
市净率:5.01
市盈率(LYR):-0.86

数据加载中...

2022/06/10

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/06/03

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/06/02

重要事件披露

8-K - Current report
2022/06/01

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/05/31

重要事件披露

8-K - Current report
2022/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/10

重要事件披露

8-K - Current report
2022/03/23

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/23

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/21

重要事件披露

8-K - Current report
2022/03/03

重要事件披露

8-K - Current report
2022/02/28

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/19

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/01/04

重要事件披露

8-K - Current report
2021/11/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/10

重要事件披露

8-K - Current report
2021/11/09

重要事件披露

8-K - Current report